Skip to main content
Dr. Asma Patel , Articles & Publications

Dr. Asma Patel featured in Medicine Maker, "Streamlining the Path to First-in-Human Trials"

icon 6

In this article by The Medicine Maker, Dr. Asma Patel, VP of Integrated Development Services at Quotient Sciences discusses how accelerating first-in-human (FiH) clinical trials is crucial in drug development, especially for orphan drugs treating rare diseases.

Asma points out how a simplified formulation approach, such as a drug-in-capsule method, can streamline the process.

Continue reading the full article on The Medicine Maker

Latest news from Quotient Sciences

More News
News & Announcements, Articles & Publications, John McDermott Quotient Sciences’ John McDermott Contributes to Pharmaceutical Outsourcing Oral Solid Dosage Roundtable By: John McDermott
Read More
News & Announcements, Articles & Publications, John McDermott Q&A with Quotient Sciences’ John McDermott: Exploring the Benefits of Partnering with a CRDMO By: John McDermott
Read More
Get in touch
Humanity can't afford to wait, so neither can we.